Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (unaudited)

v3.25.1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 182 $ 166
Selling, general and administrative 29 27
Total operating expenses 211 193
Loss from operations (211) (193)
Other income (expense):    
Change in fair value of derivative liabilities (9) 12
Other income, net 12 16
Loss before income taxes (208) (165)
Income tax expense 0 0
Net loss $ (208) $ (165)
Basic net loss per share (in usd per share) $ (0.12) $ (0.11)
Diluted net loss per share (in usd per share) $ (0.12) $ (0.11)
Basic weighted-average shares outstanding (in shares) 1,744 1,537
Diluted weighted-average shares outstanding (in shares) 1,744 1,537